Nanoparticulates

Haschek and Rousseaux's Handbook of Toxicologic Pathology

Volumn , Issue , 2013, Pages 1373-1419

  Hubbs, Ann ^a   Porter, Dale W ^a   Mercer, Robert ^a   Castranova, Vincent ^a   Sargent, Linda ^a   Sriram, Krishnan ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Endocytosis; Genotoxicity; Lymphatics; Microscopy; Nanomedicine; Nanoparticle; Nanotechnology; Nanotoxicology; Neurotoxicology; Pathology

Indexed keywords

EID: 84884083414     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415759-0.00043-1     Document Type: Chapter

References (367)

1. Brauman J.I. Room at the Bottom. Science 1991, 254. 1277-1277.
2. Hubbs A.F., Mercer R.R., Benkovic S.A., Harkema J., Sriram K., Schwegler-Berry D., Goravanahally M.P., Nurkiewicz T.R., Castranova V., Sargent L.M. Nanotoxicology - a pathologist's perspective. Toxicol. Pathol. 2011, 39:301-324.
3. National Science and Technology Council Committee on Technology Subcommittee on Nanoscale Science Engineering and Technology: The National Nanotechnology Initiative, Supplement to the President's FY2012 Budget. Edited by National Science and Technology Council. Arlinton, VA., National Nanotechnology Coordination Office , 2011, p. 50. http://www.nano.gov/sites/default/files/pub_resource/nni_2012_budget_sup plement.pdf.
4. SCENIHR: The Scientific Aspects of the Existing and Proposed Definitions Relating to Products of Nanoscience and Nanotechnologies. Edited by Brussels, European Commission. Health & Consumer Protection DG., 29 November 2007, p. 22.
5. SCENIHR: Scientific Committee on Emerging and Newly Identified Health Risks: Scientific Basis for the Definition of the Term "nanomaterial". Edited by Brussels, European Commission. Directorate-General for Heatlh and Consumers., 8 December 2010, p. 46.
6. Whitesides G.M., Mathias J.P., Seto C.T. Molecular self-assembly and nanochemistry: a chemical strategy for the synthesis of nanostructures. Science 1991, 254:1312-1319.
7. Bean J.C., et al. UVA Virtual Lab: Nanocarbon from Graphene to Nanotubes to Buckyballs 2011, University of Virginia, Charlottesville, VA. http://www.virlab.virginia.edu/VL/Nanocarbon.htm, J.C. Bean (Ed.).
8. Binnig G., Rohrer H. Scanning Tunneling Microscopy. IBM. J. Res. Dev. 1986, 30:355-369.
9. Binnig G., Rohrer H. Scanning Tunneling Microscopy - from Birth to Adolescence. Angew. Chem. Int. Edit. 1987, 26:606-614.
10. Charlier J.C., De Vita A., Blase X., Car R. Microscopic Growth Mechanisms for Carbon Nanotubes. Science 1997, 275:646-649.
11. Curl R.F., Smalley R.E. Probing c60. Science 1988, 242:1017-1022.
12. Curl R.F. Dawn of the fullerenes: Conjecture and experiment (Nobel lecture). Angew. Chem. Int. Edit. 1997, 36:1567-1576.
13. Government Accountability Office (as edited by the journal) United States Government Accountability Office report on nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk. Int. J. Occup. Environ. Health 2010, 16:525-539.
14. Iijima S. Helical Microtubules of Graphitic Carbon. Nature 1991, 354:56-58.
15. Iijima S., Ichihashi T. Single-shell carbon nanotubes of 1-nm diameter. Nature 1993, 363:603-605.
16. Kroto H. Symmetry, space, stars, and C-60 (Nobel lecture). Angew. Chem. Int. Edit. 1997, 36:1579-1593.
17. Kroto H.W., Heath J.R., O'Brien S.C., Curl R.F., Smalley R.E. C60: Buckminsterfullerene. Nature 1985, 318:162-163.
18. Law M., Goldberger J., Yang P.D. Semiconductor nanowires and nanotubes. Annu. Rev. Mater. Res. 2004, 34:83-122.
19. Randic M., Kroto H.W., Vukicevic D. Numerical Kekule structures of fullerenes and partitioning of pi-electrons to pentagonal and hexagonal rings. J. Chem. Inf. Model. 2007, 47:897-904.
20. Ruska E. The Emergence of the Electron-Microscope - Connection between Realization and 1st Patent Application, Documents of an Invention. J. Ultra Mol. Struct. R. 1986, 95:3-28.
21. Ruska E. The Development of the Electron-Microscope and of Electron-Microscopy (Nobel Lecture). Angew. Chem. Int. Edit. 1987, 26:595-605.
22. Ruska E. A modern electron microscope. Minerva. Med. 1955, 46:597-599.
23. Smalley R.E. Discovering the fullerenes (Nobel lecture). Angew. Chem. Int. Edit. 1997, 36:1595-1601.
24. Taylor R., Walton D.R.M. The chemistry of fullerenes. Nature 1993, 363:685-693.
25. Ajayan P.M., Charlier J., Rinzler A.G. Carbon nanotubes: from macromolecules to nanotechnology. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:14199-14200.
26. Appenzeller T. The Man Who Dared to Think Small. Science 1991, 254:1300-1301.
27. Bean J.C., et al. UVA Virtual Lab: Nanocarbon from Graphene to Nanotubes to Buckyballs 2011, University of Virginia, Charlottesville, VA. http://www.virlab.virginia.edu/VL/Nanocarbon.htm, J.C. Bean (Ed.).
28. Brauman J.I. Room at the Bottom. Science 1991, 254. 1277-1277.
29. Chen J.H., Seeman N.C. Synthesis from DNA of a molecule with the connectivity of a cube. Nature 1991, 350:631-633.
30. Collins P.G., Zettl A., Bando H., Thess A., Smalley R.E. Nanotube nanodevice. Science 1997, 278:100-103.
31. Environmental Protection Agency Nanotechnology White Paper 2007, 120. Environmental Protection Agency, Washington DC, US. S.P.C.N. Workgroup (Ed.).
32. Gass M.H., Bangert U., Bleloch A.L., Wang P., Nair R.R., Geim A.K. Free-standing graphene at atomic resolution. Nat. Nanotechnol. 2008, 3:676-681.
33. Ghadiri M.R., Granja J.R., Milligan R.A., Mcree D.E., Khazanovich N. Self-Assembling Organic Nanotubes Based on a Cyclic Peptide Architecture. Nature 1993, 366:324-327.
34. Hamada N., Sawada S., Oshiyama A. New One-Dimensional Conductors - Graphitic Microtubules. Phys. Rev. Lett. 1992, 68:1579-1581.
35. Harada A., Li J., Kamachi M. The Molecular Necklace - a Rotaxane Containing Many Threaded Alpha-Cyclodextrins. Nature 1992, 356:325-327.
36. Iijima S., Ichihashi T. Single-shell carbon nanotubes of 1-nm diameter. Nature 1993, 363:603-605.
37. Kroto H.W., Heath J.R., O'Brien S.C., Curl R.F., Smalley R.E. C60: Buckminsterfullerene. Nature 1985, 318:162-163.
38. Li G., Mcgown L.B. Molecular Nanotube Aggregates of Beta-Cyclodextrins and Gamma-Cyclodextrins Linked by Diphenylhexatrienes. Science 1994, 264:249-251.
39. Mintmire J.W., Dunlap B.I., White C.T. Are Fullerene Tubules Metallic. Phys. Rev. Lett. 1992, 68:631-634.
40. Perepichka D.F., Rosei F. Silicon nanotubes. Small 2006, 2:22-25.
41. Ruseckas J., Juzeliunas G., Zozoulenko I.V. Spectrum of pi electrons in bilayer graphene nanoribbons and nanotubes: An analytical approach. Phys. Rev. B 2011, 83. 035403.
42. Saito S. Carbon nanotubes for next-generation electronics devices. Science 1997, 278:77-78.
43. Seeman N.C. Construction of three-dimensional stick figures from branched DNA. DNA. Cell Biol. 1991, 10:475-486.
44. Smalley R.E. Discovering the fullerenes (Nobel Lecture). Angew. Chem. Int. Edit. 1997, 36:1595-1601.
45. Sundaram M., Chalmers S.A., Hopkins P.F., Gossard A.C. New quantum structures. Science 1991, 254:1326-1335.
46. Stroscio J.A., Eigler D.M. Atomic and molecular manipulation with the scanning tunneling microscope. Science 1991, 254:1319-1326.
47. Whitesides G.M., Mathias J.P., Seto C.T. Molecular self-assembly and nanochemistry: a chemical strategy for the synthesis of nanostructures. Science 1991, 254:1312-1319.
48. Bawa R., Bawa S.R., Maebius S.B., Flynn T., Wei C. Protecting new ideas and inventions in nanomedicine with patents. Nanomedicine 2005, 1:150-158.
49. Bawarski W.E., Chidlowsky E., Bharali D.J., Mousa S.A. Emerging nanopharmaceuticals. Nanomedicine 2008, 4:273-282.
50. Bhaskar S., Tian F., Stoeger T., Kreyling W., de la Fuente J.M., Grazu V., Borm P., Estrada G., Ntziachristos V., Razansky D. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part. Fibre. Toxicol. 2010, 7:3.
51. Blanco E., Hsiao A., Mann A.P., Landry M.G., Meric-Bernstam F., Ferrari M. Nanomedicine in cancer therapy: Innovative trends and prospects. Cancer Sci. 2011, 102:1247-1252.
52. Brambilla D., Le Droumaguet B., Nicolas J., Hashemi S.H., Wu L.P., Moghimi S.M., Couvreur P., Andrieux K. Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues. Nanomedicine 2011, 7:521-540.
53. Chen X., Gambhir S.S., Cheon J. Theranostic nanomedicine. Acc. Chem. Res. 2011, 44:841.
54. Chrastina A., Massey K.A., Schnitzer J.E. Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2011, 3:421-437.
55. Environmental Protection Agency Pollution Prevention and Toxics: Control of nanoscale materials under the Toxic Substances Control Act . http://www.epa.gov/oppt/nano/.
56. Environmental Protection Agency 40 CFR parts 704, 710 and 711, TSCA inventory update reporting modifications; chemical data reporting; final rule. Federal Register 2011, 76:50816-50879.
57. Environmental Protection Agency Nanotechnology White Paper 2007, Washington DC, U.S. Environmental Protection Agency. http://www.epa.gov/osa/pdfs/nanotech/epa-nanotechnology-whitepaper-0207. pdf, Workgroup SPCN (Ed.).
58. Government Accountability Office as edited by the journal United States Government Accountability Office report on nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk. Int. J. Occup. Environ. Health 2010, 16:525-539.
59. Lux Research Inc. The Recession's Ripple Effect on Nanotech. 2009. Boston, MA 02109.
60. Ng K.K., Lovell J.F., Zheng G. Lipoprotein-inspired nanoparticles for cancer theranostics. Acc. Chem. Res. 2011, 44:1105-1113.
61. Olakowska E., Woszczycka-Korczynska I., Jedrzejowska-Szypulka H., Lewin-Kowalik J. Application of nanotubes and nanofibres in nerve repair. A review. Folia. Neuropathol. 2010, 48:231-237.
62. Service R.F. Nanotoxicology: Nanotechnology grows up. Science 2004, 304:1732-1734.
63. Wagner V., Dullaart A., Bock A.K., Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 2006, 24:1211-1217.
64. Wang Z., Tiruppathi C., Cho J., Minshall R.D., Malik A.B. Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB. Life 2011, 63:659-667.
65. Wang Z., Tiruppathi C., Minshall R.D., Malik A.B. Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS. Nano. 2009, 3:4110-4116.
66. Woodrow Wilson International Center for Scholars and the Pew Charitable Trusts: Analysis, Consumer Products Inventory, The Project on Emerging Technologies, . http://www.nanotechproject.org/inventories/consumer/analysis_draft/.
67. Woodrow Wilson International Center for Scholars and the Pew Cheritable Trusts: The Project on Emerging Nanotechnology. Edited by Woodrow Wilson International Center for Scholars and the Pew Cheritable Trusts. 2011. http://www.nanotechproject.org/.
68. Yoo J.W., Irvine D.J., Discher D.E., Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 2011, 10:521-535.
69. Yuan X., Naguib S., Wu Z. Recent advances of siRNA delivery by nanoparticles. Expert. Opin. Drug Deliv. 2011, 8:521-536.
70. Abbey D.E., Nishino N., McDonnell W.F., Burchette R.J., Knutsen S.F., Lawrence Beeson W., Yang J.X. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am. J. Respir. Crit. Care. Med. 1999, 159:373-382.
71. Abbott L.C., Maynard A.D. Exposure assessment approaches for engineered nanomaterials. Risk. Anal. 2010, 30:1634-1644.
72. Daniels M.J., Dominici F., Samet J.M., Zeger S.L. Estimating particulate matter-mortality dose-response curves and threshold levels: an analysis of daily time-series for the 20 largest US cities. Am. J. Epidemiol. 2000, 152:397-406.
73. Daniels M.J., Dominici F., Zeger S.L., Samet J.M. The National Morbidity, Mortality, and Air Pollution Study. Part III: PM10 concentration-response curves and thresholds for the 20 largest US cities, Res Rep Health Eff Inst 2004, 1-21. discussion 23-30.
74. Eftim S.E., Samet J.M., Janes H., McDermott A., Dominici F. Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a medicare cohort. Epidemiology 2008, 19:209-216.
75. Han J.H., Lee E.J., Lee J.H., So K.P., Lee Y.H., Bae G.N., Lee S.B., Ji J.H., Cho M.H., Yu I.J. Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal. Toxicol. 2008, 20:741-749.
76. Herrick R.F. Research Need 1: Characterize Exposures Among Workers 2011, 9-21. online, National Nanotechnology Initiative. http://www.nano.gov/sites/default/files/pub_resource/humanandenvironment alexposureassessment_0.pdf, V. Murashov (Ed.).
77. Hubbs A., Greskevitch M., Kuempel E., Suarez F., Toraason M. Abrasive blasting agents: designing studies to evaluate relative risk. J. Toxicol. Environ. Health A 2005, 68:999-1016.
78. Hubbs A.F., Mercer R.R., Benkovic S.A., Harkema J., Sriram K., Schwegler-Berry D., Goravanahally M.P., Nurkiewicz T.R., Castranova V., Sargent L.M. Nanotoxicology - a pathologist's perspective. Toxicol. Pathol. 2011, 39:301-324.
79. Johnson D.R., Methner M.M., Kennedy A.J., Steevens J.A. Potential for occupational exposure to engineered carbon-based nanomaterials in environmental laboratory studies. Environ. Health A Perspect. 2010, 118:49-54.
80. Lee J.H., Lee S.B., Bae G.N., Jeon K.S., Yoon J.U., Ji J.H., Sung J.H., Lee B.G., Lee J.H., Yang J.S., Kim H.Y., Kang C.S., Yu I.J. Exposure assessment of carbon nanotube manufacturing workplaces. Inhal. Toxicol. 2010, 22:369-381.
81. Maynard A.D., Baron P.A., Foley M., Shvedova A.A., Kisin E.R., Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J. Toxicol. Environ. Health A 2004, 67:87-107.
82. Maynard A.D., Kuempel E.D. Airborne nanostructured particles and occupational health. J. Nanopart. Res. 2005, 7:587-614.
83. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Schwegler-Berry D., Castranova V., Porter D.W. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre. Toxicol. 2010, 7:28.
84. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Friend S., Castranova V., Porter D.W. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre. Toxicol. 2011, 8:21.
85. Methner M.M., Birch M.E., Evans D.E., Ku B.K., Crouch K., Hoover M.D. Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations. J. Occup. Environ. Hyg. 2007, 4:D125-D130.
86. Methner M.M. Engineering case reports. Effectiveness of local exhaust ventilation (LEV) in controlling engineered nanomaterial emissions during reactor cleanout operations. J. Occup. Environ. Hyg. 2008, 5:D63-D69.
87. Nazarenko Y., Han T.W., Lioy P.J., Mainelis G. Potential for exposure to engineered nanoparticles from nanotechnology-based consumer spray products. J. Expo. Sci. Environ. Epidemiol. 2011, 21:515-528.
88. Nemmar A., Hoet P.H.M., Vanquickenborne B., Dinsdale D., Thomeer M., Hoylaerts M.F., Vanbilloen H., Mortelmans L., Nemery B. Passage of Inhaled Particles Into the Blood Circulation in Humans. Circulation 2002, 105:411-414.
89. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre. Toxicol. 2005, 2:8.
90. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Lunts A., Kreyling W., Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health A 2002, 65:1531-1543.
91. OSHA 29 CFR - Occupational Safety and Health Regulations (OSHA Standards) 2006, Occupational Safety & Health Administration. http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=9992, US Department of Labor (Ed.).
92. Peters T.M., Elzey S., Johnson R., Park H., Grassian V.H., Maher T., O'Shaughnessy P. Airborne monitoring to distinguish engineered nanomaterials from incidental particles for environmental health and safety. J. Occup. Environ. Hyg. 2009, 6. 73-1.
93. Porter D.W., Hubbs A.F., Mercer R.R., Wu N., Wolfarth M.G., Sriram K., Leonard S., Battelli L., Schwegler-Berry D., Friend S., Andrew M., Chen B.T., Tsuruoka S., Endo M., Castranova V. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269:136-147.
94. Ramachandran G., Ostraat M., Evans D.E., Methner M.M., O'Shaughnessy P., D'Arcy J., Geraci C.L., Stevenson E., Maynard A., Rickabaugh K. A strategy for assessing workplace exposures to nanomaterials. J. Occup. Environ. Hyg. 2011, 8:673-685.
95. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung. Cell Mol. Physiol. 2005, 289:L698-L708.
96. Shvedova A.A., Kisin E., Murray A.R., Johnson V.J., Gorelik O., Arepalli S., Hubbs A.F., Mercer R.R., Keohavong P., Sussman N., Jin J., Yin J., Stone S., Chen B.T., Deye G., Maynard A., Castranova V., Baron P.A., Kagan V.E. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung. Cell Mol. Physiol. 2008, 295:L552-L565.
97. Stern S.T., McNeil S.E. Nanotechnology safety concerns revisited. Toxicol. Sci. 2008, 101:4-21.
98. Tinkle S.S., Antonini J.M., Rich B.A., Roberts J.R., Salmen R., DePree K., Adkins E.J. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ. Health Perspect. 2003, 111:1202-1208.
99. Turner M.C., Krewski D., Pope Iii C.A., Chen Y., Gapstur S.M., Thun M.J. Long-Term Ambient Fine Particulate Matter Air Pollution and Lung Cancer in a Large Cohort of Never Smokers. Am. J. Respir. Crit. Care. Med. 2011, 184:1374-1381.
100. Wagner V., Dullaart A., Bock A.K., Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 2006, 24:1211-1217.
101. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., Sun J., Li Y., Jiao F., Zhao Y., Chai Z. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168:176-185.
102. Wichmann H.E., Spix C., Tuch T., Wolke G., Peters A., Heinrich J., Kreyling W.G., Heyder J. Daily mortality and fine and ultrafine particles in Erfurt, Germany part I: role of particle number and particle mass. Res. Rep. Health Eff. Inst. 2000, 5-86. discussion 87-94.
103. Woodrow Wilson International Center for Scholars and the Pew Cheritable Trusts: Analysis, Consumer Products Inventory, The Project on Emerging Technologies, . http://www.nanotechproject.org/inventories/consumer/analysis_draft/.
104. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre. Toxicol. 2005, 2:8.
105. Warheit D.B., Sayes C.M., Reed K.L., Swain K.A. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol. Ther. 2008, 120:35-42.
106. Donaldson K., Brown D., Clouter A., Duffin R., MacNee W., Renwick L., Tran L., Stone V. The pulmonary toxicology of ultrafine particles. J. Aerosol. Med. 2002, 15:213-220.
107. Duffin R., Tran L., Brown D., Stone V., Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol. 2007, 19:849-856.
108. Ferin J., Oberdorster G., Penney D.P. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 1992, 6:535-542.
109. Oberdorster G. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal. Toxicol. 1996, (Suppl. 8):73-89.
110. Oberdorster G., Ferin J., Lehnert B.E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 1994, 102(Suppl. 5):173-179.
111. Sager T.M., Castranova V. Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part Fibre. Toxicol. 2009, 6:15.
112. Sager T.M., Kommineni C., Castranova V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre. Toxicol. 2008, 5:17.
113. Shvedova A.A., Sager T.,Kisin E., Porter D.W., Leonard S.S., Schwegler-Berry D., Robinson V.A., Castranova V. Critical Issues in the Evaluation of Possible Adverse Pulmonary Effects Resulting from Airborne Nanoparticles 2007, 225-236. Informa Healthcare USA, Inc., New York. N.A. Monteiro-Riviere, C.L. Tran (Eds.).
114. Tran C.L., Buchanan D., Cullen R.T., Searl A., Jones A.D., Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal. Toxicol. 2000, 12:1113-1126.
115. George S., Pokhrel S., Xia T., Gilbert B., Ji Z., Schowalter M., Rosenauer A., Damoiseaux R., Bradley K.A., Madler L., Nel A.E. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS. Nano. 2010, 4:15-29.
116. Hakkinen H., Abbet W., Sanchez A., Heiz U., Landman U. Structural, electronic, and impurity-doping effects in nanoscale chemistry: Supported gold nanoclusters. Angew. Chem. Int. Ed. 2003, 42:1297-1300.
117. Ma R., Levard C., Marinakos S.M., Cheng Y., Liu J., Michel F.M., Brown G.E., Lowry G.V. Size-controlled dissolution of organic-coated silver nanoparticles. Environ. Sci. Technol. 2012, 46:752-759.
118. Roco M.C. Nanoparticles and nanotechnology research. J. Nanopart. Res. 1999, 1:1-6.
119. Sager T.M., Molina R., Donaghey T., Brain J., Castranova V. Effects of particle size and route of exposure on the bioavailability of zinc from nano-sized zinc oxide particles. Toxicol. Sci. (The Toxicologist) 2010, 114(60). (abstract) available at. http://www.toxicology.org/ms/AMpubs.asp.
120. Volokitin Y., Sinzig J., deJongh L.J., Schmid G., Vargaftik M.N., Moiseev I.I. Quantum-size effects in the thermodynamic properties of metallic nanoparticles. Nature 1996, 384:621-623.
121. Xia T., Zhao Y., Sager T., George S., Pokhrel S., Li N., Schoenfeld D., Meng H., Lin S., Wang X., Wang M., Ji Z., Zink J.I., Madler L., Castranova V., Lin S., Nel A.E. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS. Nano. 2011, 5:1223-1235.
122. Mercer R.R., Russell M.L., Crapo J.D. Alveolar septal structure in different species. J. Appl. Physiol. 1994, 77:1060-1066.
123. Mercer R.R., Scabilloni J., Wang L., Kisin E., Murray A.R., Schwegler-Berry D., Shvedova A.A., Castranova V. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am. J. Physiol. Lung. Cell Mol. Physiol. 2008, 294:L87-L97.
124. Porter D.W., Hubbs A.F., Mercer R.R., Wu N., Wolfarth M.G., Sriram K., Leonard S., Battelli L., Schwegler-Berry D., Friend S., Andrew M., Chen B.T., Tsuruoka S., Endo M., Castranova V. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269:136-147.
125. Sager T.M., Porter D.W., Robinson V.A., Lindsley W.G., Schwegler-Berry D.E., Castranova V. Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology 2007, 1:118-129.
126. Mercer R.R., Scabilloni J., Wang L., Kisin E., Murray A.R., Schwegler-Berry D., Shvedova A.A., Castranova V. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am. J. Physiol. Lung. Cell Mol. Physiol. 2008, 294:L87-L97.
127. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Schwegler-Berry D., Castranova V., Porter D.W. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre. Toxicol. 2010, 7:28.
128. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Friend S., Castranova V., Porter D.W. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre. Toxicol. 2011, 8:21.
129. Al-Jamal K.T., Nerl H., Muller K.H., Ali-Boucetta H., Li S., Haynes P.D., Jinschek J.R., Prato M., Bianco A., Kostarelos K., Porter A.E. Cellular uptake mechanisms of functionalised multi-walled carbon nanotubes by 3D electron tomography imaging. Nanoscale 2011, 3:2627-2635.
130. Archer V.E. Carcinogenicity of fibers and films: a theory. Med. Hypotheses 1979, 5:1257-1262.
131. Carter R.M., Yan Y. Measurement of particle shape using digital imaging techniques. Institute of Physics: Conference Series 2005, 15:177-182.
132. Donaldson K., Murphy F.A., Duffin R., Poland C.A. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre. Toxicol. 2010, 7:5.
133. Haley P.J., Muggenburg B.A., Weissman D.N., Bice D.E. Comparative morphology and morphometry of alveolar macrophages from six species. Am. J. Anat. 1991, 191:401-407.
134. Harmsen A.G., Muggenburg B.A., Snipes M.B., Bice D.E. The role of macrophages in particle translocation from lungs to lymph nodes. Science 1985, 230:1277-1280.
135. Harmsen A.G., Mason M.J., Muggenburg B.A., Gillett N.A., Jarpe M.A., Bice D.E. Migration of neutrophils from lung to tracheobronchial lymph node. J. Leukoc. Biol. 1987, 41:95-103.
136. Hubbs A.F., Mercer R.R., Benkovic S.A., Harkema J., Sriram K., Schwegler-Berry D., Goravanahally M.P., Nurkiewicz T.R., Castranova V., Sargent L.M. Nanotoxicology - a pathologist's perspective. Toxicol. Pathol. 2011, 39:301-324.
137. Krombach F., Munzing S., Allmeling A.M., Gerlach J.T., Behr J., Dorger M. Cell size of alveolar macrophages: an interspecies comparison. Environ. Health Perspect. 1997, 105(Suppl. 5):1261-1263.
138. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Schwegler-Berry D., Castranova V., Porter D.W. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre. Toxicol. 2010, 7:28.
139. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Friend S., Castranova V., Porter D.W. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre. Toxicol. 2011, 8:21.
140. Moller W., Haussinger K., Winkler-Heil R., Stahlhofen W., Meyer T., Hofmann W., Heyder J. Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects. J. Appl. Physiol. 2004, 97:2200-2206.
141. Pacurari M., Castranova V., Vallyathan V. Single- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans?. J. Toxicol. Environ. Health A. 2010, 73:378-395.
142. Porter D.W., Hubbs A.F., Mercer R.R., Wu N., Wolfarth M.G., Sriram K., Leonard S., Battelli L., Schwegler-Berry D., Friend S., Andrew M., Chen B.T., Tsuruoka S., Endo M., Castranova V. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269:136-147.
143. Porter D.W., Hubbs A., Chen T.B., McKinney W., Mercer R.R., Wolfarth M.G., Battelli L.A., Wu N., Sriram K., Leonard S., Andrew M.E., Willard P., Tsuruoka T., Endo M., Tsukada T., Munekane F., Frazer D.G., Castranova V. Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 2012, in press.
144. Shi X., von dem Bussche A., Hurt R.H., Kane A.B., Gao H. Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat. Nanotechnol. 2011, 6:714-719.
145. Stanton M.F., Layard M., Tegeris A., Miller E., May M., Morgan E., Smith A. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J. Natl. Cancer Inst. 1981, 67:965-975.
146. Zeidler-Erdely P.C., Calhoun W.J., Ameredes B.T., Clark M.P., Deye G.J., Baron P., Jones W., Blake T., Castranova V. In vitro cytotoxicity of Manville Code 100 glass fibers: effect of fiber length on human alveolar macrophages. Part Fibre. Toxicol. 2006, 3:5.
147. Sargent L.M., Shvedova A.A., Hubbs A.F., Salisbury J.L., Benkovic S.A., Kashon M.L., Lowry D.T., Murray A.R., Kisin E.R., Friend S., McKinstry K.T., Battelli L., Reynolds S.H. Induction of aneuploidy by single-walled carbon nanotubes. Environ. Mol. Mutagen. 2009, 50:708-717.
148. Sargent L.M., Hubbs A.F., Young S.-H., Kashon M.L., Dinu C.Z., Salisbury J.L., Benkovic S.A., Lowry D.T., Murray A.R., Kisin E.R., Siegrist K.J., Battelli L., Mastovich J., Sturgeon J.L., Bunker K.L., Shvedova A.A., Reynolds S.H. Single-walled carbon nanotube-induced mitotic disruption. Muta. Res. 2012, 745:28-37.
149. Shvedova A.A., Kisin E., Murray A.R., Johnson V.J., Gorelik O., Arepalli S., Hubbs A.F., Mercer R.R., Keohavong P., Sussman N., Jin J., Yin J., Stone S., Chen B.T., Deye G., Maynard A., Castranova V., Baron P.A., Kagan V.E. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung. Cell Mol. Physiol. 2008, 295:L552-L565.
150. Doxsey S., Zimmerman W., Mikule K. Centrosome control of the cell cycle. Trends Cell Biol. 2005, 15:303-311.
151. Hornick J.E., Bader J.R., Tribble E.K., Trimble K., Breunig J.S., Halpin E.S., Vaughan K.T., Hinchcliffe E.H. Live-cell analysis of mitotic spindle formation in taxol-treated cells. Cell Motil. Cytoskeleton 2008, 65:595-613.
152. Lingle W.L., Salisbury J.L. Methods for the analysis of centrosome reproduction in cancer cells. Methods Cell Biol. 2001, 67:325-336.
153. Lingle W.L., Lukasiewicz K., Salisbury J.L. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer. Adv. Exp. Med. Biol. 2005, 570:393-421.
154. Mullins J.M., McIntosh J.R. Isolation and initial characterization of the mammalian midbody. J. Cell Biol. 1982, 94:654-661.
155. Pihan G.A., Purohit A., Wallace J., Knecht H., Woda B., Quesenberry P., Doxsey S.J. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998, 58:3974-3985.
156. Salisbury J.L. Breaking the ties that bind centriole numbers. Nat. Cell Biol. 2008, 10:255-257.
157. Salisbury J.L., D'Assoro A.B., Lingle W.L. Centrosome amplification and the origin of chromosomal instability in breast cancer. J. Mammary Gland Biol. Neoplasia 2004, 9:275-283.
158. Yeates T.O., Padilla J.E. Designing supramolecular protein assemblies. Curr. Opin. Struct. Biol. 2002, 12:464-470.
159. Sargent L.M., Shvedova A.A., Hubbs A.F., Salisbury J.L., Benkovic S.A., Kashon M.L., Lowry D.T., Murray A.R., Kisin E.R., Friend S., McKinstry K.T., Battelli L., Reynolds S.H. Induction of aneuploidy by single-walled carbon nanotubes. Environ. Mol. Mutagen. 2009, 50:708-717.
160. Sargent L.M., Hubbs A.F., Young S.-H., Kashon M.L., Dinu C.Z., Salisbury J.L., Benkovic S.A., Lowry D.T., Murray A.R., Kisin E.R., Siegrist K.J., Battelli L., Mastovich J., Sturgeon J.L., Bunker K.L., Shvedova A.A., Reynolds S.H. Single-walled carbon nanotube-induced mitotic disruption. Mutat. Res. 2012, 745:28-37.
161. Bachand M., Trent A.M., Bunker B.C., Bachand G.D. Physical factors affecting kinesin-based transport of synthetic nanoparticle cargo. J. Nanosci. Nanotechnol. 2005, 5:718-722.
162. Dalton A.B., Collins S., Munoz E., Razal J.M., Ebron V.H., Ferraris J.P., Coleman J.N., Kim B.G., Baughman R.H. Super-tough carbon-nanotube fibres - These extraordinary composite fibres can be woven into electronic textiles. Nature 2003, 423. 703-703.
163. Dinu C.Z., Bale S.S., Zhu G.Y., Dordick J.S. Tubulin Encapsulation of Carbon Nanotubes into Functional Hybrid Assemblies. Small 2009, 5:310-315.
164. Ochi T. Role of mitotic motors, dynein and kinesin, in the induction of abnormal centrosome integrity and multipolar spindles in cultured V79 cells exposed to dimethylarsinic acid. Mutat. Res. 2002, 499:73-84.
165. Pampaloni F., Florin E.L. Microtubule architecture: inspiration for novel carbon nanotube-based biomimetic materials. Trends Biotechnol. 2008, 26:302-310.
166. Sargent L.M., Shvedova A.A., Hubbs A.F., Salisbury J.L., Benkovic S.A., Kashon M.L., Lowry D.T., Murray A.R., Kisin E.R., Friend S., McKinstry K.T., Battelli L., Reynolds S.H. Induction of aneuploidy by single-walled carbon nanotubes. Environ. Mol. Mutagen. 2009, 50:708-717.
167. Sargent L.M., Reynolds S.H., Castranova V. Potential pulmonary effects of engineered carbon nanotubes: in vitro genotoxic effects. Nanotoxicology 2010, 4:396-408.
168. Yeates T.O., Padilla J.E. Designing supramolecular protein assemblies. Curr. Opin. in Struct. Biol. 2002, 12:464-470.
169. Doak S.H., Griffiths S.M., Manshian B., Singh N., Williams P.M., Brown A.P., Jenkins G.J. Confounding experimental considerations in nanogenotoxicology. Mutagenesis 2009, 24:285-293.
170. Folkmann J.K., Risom L., Jacobsen N.R., Wallin H., Loft S., Moller P. Oxidatively damaged DNA in rats exposed by oral gavage to C60 fullerenes and single-walled carbon nanotubes. Environ. Health Perspect. 2009, 117:703-708.
171. Jacobsen N.R., Moller P., Jensen K.A., Vogel U., Ladefoged O., Loft S., Wallin H. Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice. Part Fibre. Toxicol. 2009, 6:2.
172. Kisin E.R., Murray A.R., Keane M.J., Shi X.C., Schwegler-Berry D., Gorelik O., Arepalli S., Castranova V., Wallace W.E., Kagan V.E., Shvedova A.A. Single-walled carbon nanotubes: geno- and cytotoxic effects in lung fibroblast V79 cells. J. Toxicol. Environ. Health A 2007, 70:2071-2079.
173. Li X., Peng Y., Ren J., Qu X. Carboxyl-modified single-walled carbon nanotubes selectively induce human telomeric i-motif formation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:19658-19663.
174. Li X., Peng Y., Qu X. Carbon nanotubes selective destabilization of duplex and triplex DNA and inducing B-A transition in solution. Nucleic. Acids. Res. 2006, 34:3670-3676.
175. Lindberg H.K., Falck G.C., Suhonen S., Vippola M., Vanhala E., Catalan J., Savolainen K., Norppa H. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicol. Lett. 2009, 186:166-173.
176. Muller J., Decordier I., Hoet P.H., Lombaert N., Thomassen L., Huaux F., Lison D., Kirsch-Volders M. Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells. Carcinogenesis 2008, 29:427-433.
177. Pacurari M., Yin X.J., Zhao J., Ding M., Leonard S.S., Schwegler-Berry D., Ducatman B.S., Sbarra D., Hoover M.D., Castranova V., Vallyathan V. Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-kappaB, and Akt in normal and malignant human mesothelial cells. Environ. Health Perspect. 2008, 116:1211-1217.
178. Pulskamp K., Diabate S., Krug H.F. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol. Lett. 2007, 168:58-74.
179. Sargent L.M., Shvedova A.A., Hubbs A.F., Salisbury J.L., Benkovic S.A., Kashon M.L., Lowry D.T., Murray A.R., Kisin E.R., Friend S., McKinstry K.T., Battelli L., Reynolds S.H. Induction of aneuploidy by single-walled carbon nanotubes. Environ. Mol. Mutagen. 2009, 50:708-717.
180. Sargent L.M., Hubbs A.F., Young S.-H., Kashon M.L., Dinu C.Z., Salisbury J.L., Benkovic S.A., Lowry D.T., Murray A.R., Kisin E.R., Siegrist K.J., Battelli L., Mastovich J., Sturgeon J.L., Bunker K.L., Shvedova A.A., Reynolds S.H. Single-walled carbon nanotube-induced mitotic disruption. Mutat. Res. 2012, 745:28-37.
181. Yang H., Liu C., Yang D., Zhang H., Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 2009, 29:69-78.
182. Battelli L.A., Ghanem M.M., Kashon M.L., Barger M., Ma J.Y., Simoskevitz R.L., Miles P.R., Hubbs A.F. Crystalline silica is a negative modifier of pulmonary cytochrome P-4501A1 induction. J. Toxicol. Environ. Health A. 2008, 71:521-532.
183. Bhaskar S., Tian F., Stoeger T., Kreyling W., de la Fuente J.M., Grazu V., Borm P., Estrada G., Ntziachristos V., Razansky D. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre. Toxicol. 2010, 7:3.
184. Brambilla D., Le Droumaguet B., Nicolas J., Hashemi S.H., Wu L.P., Moghimi S.M., Couvreur P., Andrieux K. Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues. Nanomedicine 2011, 7:521-540.
185. Chen X., Kube D.M., Cooper M.J., Davis P.B. Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA. Mol. Ther. 2008, 16:333-342.
186. Chen X., Shank S., Davis P.B., Ziady A.G. Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid. Mol. Ther. 2011, 19:93-102.
187. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2003, 422:37-44.
188. Cullen P.J., Korswagen H.C. Sorting nexins provide diversity for retromer-dependent trafficking events. Nat. Cell Biol. 2012, 14:29-37.
189. De Jong W.H., Borm P.J. Drug delivery and nanoparticles:applications and hazards. Int. J. Nanomedicine 2008, 3:133-149.
190. Dinsdale D. Lung injury: cell-specific bioactivation/deactivation of circulating pneumotoxins. Int. J. Exp. Pathol. 1995, 76:393-401.
191. Dvorak Z., Ulrichova J., Modriansky M. Role of microtubules network in CYP genes expression. Curr. Drug Metab. 2005, 6:545-552.
192. Evans C.W., Fitzgerald M., Clemons T.D., House M.J., Padman B.S., Shaw J.A., Saunders M., Harvey A.R., Zdyrko B., Luzinov I., Silva G.A., Dunlop S.A., Iyer K.S. Multimodal analysis of PEI-mediated endocytosis of nanoparticles in neural cells. ACS. Nano. 2011, 5:8640-8648.
193. Ghanem M.M., Porter D., Battelli L.A., Vallyathan V., Kashon M.L., Ma J.Y., Barger M.W., Nath J., Castranova V., Hubbs A.F. Respirable coal dust particles modify cytochrome P4501A1 (CYP1A1) expression in rat alveolar cells. Am. J. Respir. Cell Mol. Biol. 2004, 31:171-183.
194. Ghanem M.M., Battelli L.A., Mercer R.R., Scabilloni J.F., Kashon M.L., Ma J.Y., Nath J., Hubbs A.F. Apoptosis and Bax expression are increased by coal dust in the polycyclic aromatic hydrocarbon-exposed lung. Environ. Health Perspect. 2006, 114:1367-1373.
195. Haining R.L., Nichols-Haining M. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?. Pharmacol. Ther. 2007, 113:537-545.
196. Howes M.T., Kirkham M., Riches J., Cortese K., Walser P.J., Simpson F., Hill M.M., Jones A., Lundmark R., Lindsay M.R., Hernandez-Deviez D.J., Hadzic G., McCluskey A., Bashir R., Liu L., Pilch P., McMahon H., Robinson P.J., Hancock J.F., Mayor S., Parton R.G. Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J. Cell Biol. 2010, 190:675-691.
197. Kaksonen M., Toret C.P., Drubin D.G. Harnessing actin dynamics for clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2006, 7:404-414.
198. Lockman P.R., Koziara J.M., Mumper R.J., Allen D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J. Drug Target. 2004, 12:635-641.
199. Lovric J., Bazzi H.S., Cuie Y., Fortin G.R., Winnik F.M., Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 2005, 83:377-385.
200. Meyer R.P., Gehlhaus M., Knoth R., Volk B. Expression and function of cytochrome p450 in brain drug metabolism. Curr. Drug Metab. 2007, 8:297-306.
201. Miksys S., Tyndale R.F. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab. Rev. 2004, 36:313-333.
202. Mkandawire M., Pohl A., Gubarevich T., Lapina V., Appelhans D., Rodel G., Pompe W., Schreiber J., Opitz J. Selective targeting of green fluorescent nanodiamond conjugates to mitochondria in HeLa cells. J. Biophotonics 2009, 2:596-606.
203. Nemmar A., Hoylaerts M.F., Hoet P.H., Vermylen J., Nemery B. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol. Appl. Pharmacol. 2003, 186:38-45.
204. Parham P. The Immune System 2009, Taylor & Francis, Abingdon, UK.
205. Perez-Martinez F.C., Guerra J., Posadas I., Cena V. Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharm. Res. 2011, 28:1843-1858.
206. Reider A., Wendland B. Endocytic adaptors - social networking at the plasma membrane. J. Cell Sci. 2011, 124:1613-1622.
207. Singh S., Kumar A., Karakoti A., Seal S., Self W.T. Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol. BioSyst. 2010, 6:1813-1820.
208. Sonawane N.D., Szoka F.C., Verkman A.S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 2003, 278:44826-44831.
209. Vondracek J., Umannova L., Machala M. Interactions of the aryl hydrocarbon receptor with inflammatory mediators: beyond CYP1A regulation. Curr. Drug Metab. 2011, 12:89-103.
210. Wang J., Byrne J.D., Napier M.E., DeSimone J.M. More effective nanomedicines through particle design. Small 2011, 7:1919-1931.
211. Wang Y., Gao S., Ye W.H., Yoon H.S., Yang Y.Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat. Mater. 2006, 5:791-796.
212. Xia T., Kovochich M., Liong M., Zink J.I., Nel A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS. Nano. 2008, 2:85-96.
213. Zhang W., Zhang Y., Lobler M., Schmitz K.P., Ahmad A., Pyykko I., Zou J. Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells. Int. J. Nanomedicine 2011, 6:535-546.
214. Zhang Y., Yang M., Park J.H., Singelyn J., Ma H., Sailor M.J., Ruoslahti E., Ozkan M., Ozkan C. A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles. Small 2009, 5:1990-1996.
215. Kipen H.M., Laskin D.L. Smaller is not always better: nanotechnology yields nanotoxicology. Am. J. Physiol. Lung. Cell Mol. Physiol. 2005, 289:L696-L697.
216. 60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect. 2004, 112:1058-1062.
217. Service R.F. Nanotoxicology: Nanotechnology grows up. Science 2004, 304:1732-1734.
218. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung. Cell Mol. Physiol. 2005, 289:L698-L708.
219. Bailey M.M., Berkland C.J. Nanoparticle formulations in pulmonary drug delivery. Med. Res. Rev. 2009, 29:196-212.
220. Blanco E., Hsiao A., Mann A.P., Landry M.G., Meric-Bernstam F., Ferrari M. Nanomedicine in cancer therapy: Innovative trends and prospects. Cancer Sci. 2011, 102:1247-1252.
221. Dombu C.Y., Kroubi M., Zibouche R., Matran R., Betbeder D. Characterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cells. Nanotechnology 2010, 21:355102.
222. Foster K.A., Yazdanian M., Audus K.L. Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J. Pharm. Pharmacol. 2001, 53:57-66.
223. Ho M., Wu K.Y., Chein H.M., Chen L.C., Cheng T.J. Pulmonary toxicity of inhaled nanoscale and fine zinc oxide particles: mass and surface area as an exposure metric. Inhal. Toxicol. 2011, 23:947-956.
224. Huang X., Li L., Liu T., Hao N., Liu H., Chen D., Tang F. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS. Nano. 2011, 5:5390-5399.
225. Johnson D.R., Methner M.M., Kennedy A.J., Steevens J.A. Potential for occupational exposure to engineered carbon-based nanomaterials in environmental laboratory studies. Environ. Health Perspect. 2010, 118:49-54.
226. Knop K., Hoogenboom R., Fischer D., Schubert U.S. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl. 2010, 49:6288-6308.
227. Lee J.H., Lee S.B., Bae G.N., Jeon K.S., Yoon J.U., Ji J.H., Sung J.H., Lee B.G., Lee J.H., Yang J.S., Kim H.Y., Kang C.S., Yu I.J. Exposure assessment of carbon nanotube manufacturing workplaces. Inhal. Toxicol. 2010, 22:369-381.
228. Lin I.C., Liang M., Liu T.Y., Monteiro M.J., Toth I. Cellular transport pathways of polymer coated gold nanoparticles. Nanomedicine 2012, 8:8-11.
229. Methner M.M., Birch M.E., Evans D.E., Ku B.K., Crouch K., Hoover M.D. Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations. J. Occup. Environ. Hyg. 2007, 4:D125-D130.
230. Nurkiewicz T.R., Porter D.W., Hubbs A.F., Cumpston J.L., Chen B.T., Frazer D.G., Castranova V. Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part Fibre. Toxicol. 2008, 5:1.
231. Nurkiewicz T.R., Porter D.W., Hubbs A.F., Stone S., Chen B.T., Frazer D.G., Boegehold M.A., Castranova V. Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol. Sci. 2009, 110:191-203.
232. Pauluhn J., Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol. Sci. 2010, 113:226-242.
233. Porter D.W., Hubbs A., Chen T.B., McKinney W., Mercer R.R., Wolfarth M.G., Battelli L.A., Wu N., Sriram K., Leonard S., Andrew M.E., Willard P., Tsuruoka T., Endo M., Tsukada T., Munekane F., Frazer D.G., Castranova V. Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 2012, in press.
234. Shvedova A.A., Kisin E., Murray A.R., Johnson V.J., Gorelik O., Arepalli S., Hubbs A.F., Mercer R.R., Keohavong P., Sussman N., Jin J., Yin J., Stone S., Chen B.T., Deye G., Maynard A., Castranova V., Baron P.A., Kagan V.E. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung. Cell Mol. Physiol. 2008, 295:L552-L565.
235. Vllasaliu D., Alexander C., Garnett M., Eaton M., Stolnik S. Fc-mediated transport of nanoparticles across airway epithelial cell layers. J. Control Release 2012, 158:479-486.
236. Ma-Hock L., Burkhardt S., Strauss V., Gamer A.O., Wiench K., van Ravenzwaay B., Landsiedel R. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal. Toxicol. 2009, 21:102-118.
237. Porter D.W., Hubbs A.F., Mercer R.R., Wu N., Wolfarth M.G., Sriram K., Leonard S., Battelli L., Schwegler-Berry D., Friend S., Andrew M., Chen B.T., Tsuruoka S., Endo M., Castranova V. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269:136-147.
238. Shvedova A.A., Kisin E., Murray A.R., Johnson V.J., Gorelik O., Arepalli S., Hubbs A.F., Mercer R.R., Keohavong P., Sussman N., Jin J., Yin J., Stone S., Chen B.T., Deye G., Maynard A., Castranova V., Baron P.A., Kagan V.E. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung. Cell Mol. Physiol. 2008, 295:L552-L565.
239. Ho M., Wu K.Y., Chein H.M., Chen L.C., Cheng T.J. Pulmonary toxicity of inhaled nanoscale and fine zinc oxide particles: mass and surface area as an exposure metric. Inhal. Toxicol. 2011, 23:947-956.
240. Pauluhn J., Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol. Sci. 2010, 113:226-242.
241. Shvedova A.A., Kisin E.R., Mercer R., Murray A.R., Johnson V.J., Potapovich A.I., Tyurina Y.Y., Gorelik O., Arepalli S., Schwegler-Berry D., Hubbs A.F., Antonini J., Evans D.E., Ku B.K., Ramsey D., Maynard A., Kagan V.E., Castranova V., Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung. Cell Mol. Physiol. 2005, 289:L698-L708.
242. Sung J.H., Ji J.H., Park J.D., Song M.Y., Song K.S., Ryu H.R., Yoon J.U., Jeon K.S., Jeong J., Han B.S., Chung Y.H., Chang H.K., Lee J.H., Kim D.W., Kelman B.J., Yu I.J. Subchronic inhalation toxicity of gold nanoparticles. Part Fibre. Toxicol. 2011, 8:16.
243. Yazdi A.S., Guarda G., Riteau N., Drexler S.K., Tardivel A., Couillin I., Tschopp J. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19449-19454.
244. Mercer R.R., Scabilloni J., Wang L., Kisin E., Murray A.R., Schwegler-Berry D., Shvedova A.A., Castranova V. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am. J. Physiol. Lung. Cell Mol. Physiol. 2008, 294:L87-L97.
245. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Friend S., Castranova V., Porter D.W. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre. Toxicol. 2011, 8:21.
246. Song Y., Li X., Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur. Respir. J. 2009, 34:559-567.
247. Wu M., Gordon R.E., Herbert R., Padilla M., Moline J., Mendelson D., Litle V., Travis W.D., Gil J. Case report: Lung disease in World Trade Center responders exposed to dust and smoke: carbon nanotubes found in the lungs of World Trade Center patients and dust samples. Environ. Health Perspect. 2010, 118:499-504.
248. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Schwegler-Berry D., Castranova V., Porter D.W. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre. Toxicol. 2010, 7:28.
249. Porter D.W., Hubbs A.F., Mercer R.R., Wu N., Wolfarth M.G., Sriram K., Leonard S., Battelli L., Schwegler-Berry D., Friend S., Andrew M., Chen B.T., Tsuruoka S., Endo M., Castranova V. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269:136-147.
250. Stanton M.F., Layard M.W. Carcinogenicity of natural and man-made fibers. Adv. Clin. Oncol. 1978, 1:181-187.
251. Stanton M.F., Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J. Natl. Cancer Inst. 1972, 48:797-821.
252. Stanton M.F., Laynard M., Tegeris A., Miller E., May M., Kent E. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J. Natl. Cancer Inst. 1977, 58:587-603.
253. Stanton M.F., Layard M., Tegeris A., Miller E., May M., Morgan E., Smith A. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J. Natl. Cancer Inst. 1981, 67:965-975.
254. Porter D.W., Hubbs A.F., Mercer R.R., Wu N., Wolfarth M.G., Sriram K., Leonard S., Battelli L., Schwegler-Berry D., Friend S., Andrew M., Chen B.T., Tsuruoka S., Endo M., Castranova V. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269:136-147.
255. Calderon-Garciduenas L., Valencia-Salazar G., Rodriguez-Alcaraz A., Gambling T.M., Garcia R., Osnaya N., Villarreal-Calderon A., Devlin R.B., Carson J.L. Ultrastructural nasal pathology in children chronically and sequentially exposed to air pollutants. Am. J. Respir. Cell Mol. Biol. 2001, 24:132-138.
256. Calderon-Garciduenas L., Maronpot R.R., Torres-Jardon R., Henriquez-Roldan C., Schoonhoven R., Acuna-Ayala H., Villarreal-Calderon A., Nakamura J., Fernando R., Reed W., Azzarelli B., Swenberg J.A. DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol. Pathol. 2003, 31:524-538.
257. Calderon-Garciduenas L., Reed W., Maronpot R.R., Henriquez-Roldan C., Delgado-Chavez R., Calderon-Garciduenas A., Dragustinovis I., Franco-Lira M., Aragon-Flores M., Solt A.C., Altenburg M., Torres-Jardon R., Swenberg J.A. Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicol. Pathol. 2004, 32:650-658.
258. Calderon-Garciduenas L., Franco-Lira M., Torres-Jardon R., Henriquez-Roldan C., Barragan-Mejia G., Valencia-Salazar G., Gonzalez-Maciel A., Reynoso-Robles R., Villarreal-Calderon R., Reed W. Pediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology. Toxicol. Pathol. 2007, 35:154-162.
259. Chen Z., Chen H., Meng H., Xing G., Gao X., Sun B., Shi X., Yuan H., Zhang C., Liu R., Zhao F., Zhao Y., Fang X. Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol. Appl. Pharmacol. 2008, 230:364-371.
260. De Jong W.H., Hagens W.I., Krystek P., Burger M.C., Sips A.J., Geertsma R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
261. Eichenbaum H., Fagan A., Mathews P., Cohen N.J. Hippocampal system dysfunction and odor discrimination learning in rats: impairment or facilitation depending on representational demands. Behav. Neurosci. 1988, 102:331-339.
262. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., Potter R., Maynard A., Ito Y., Finkelstein J., Oberdorster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 2006, 114:1172-1178.
263. Haas C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 2007, 8:101-112.
264. Hjorth-Simonsen A., Jeune B. Origin and termination of the hippocampal perforant path in the rat studied by silver impregnation. J. Comp. Neurol. 1972, 144:215-232.
265. Hunter D.D., Undem B.J. Identification and substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea. Am. J. Respir. Crit. Care. Med. 1999, 159:1943-1948.
266. Johnson G.V., Stoothoff W.H. Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 2004, 117:5721-5729.
267. Kim J.S., Yoon T.J., Yu K.N., Kim B.G., Park S.J., Kim H.W., Lee K.H., Park S.B., Lee J.K., Cho M.H. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 2006, 89:338-347.
268. Kim Y.S., Kim J.S., Cho H.S., Rha D.S., Kim J.M., Park J.D., Choi B.S., Lim R., Chang H.K., Chung Y.H., Kwon I.H., Jeong J., Han B.S., Yu I.J. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 2008, 20:575-583.
269. Kosel K.C., Van Hoesen G.W., West J.R. Olfactory bulb projections to the parahippocampal area of the rat. J. Comp. Neurol. 1981, 198:467-482.
270. Kreyling W.G., Semmler M., Erbe F., Mayer P., Takenaka S., Schulz H., Oberdorster G., Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health A 2002, 65:1513-1530.
271. Kreyling W.G., Semmler-Behnke M., Moller W. Ultrafine particle-lung interactions: does size matter?. J. Aerosol. Med. 2006, 19:74-83.
272. Kwon J.T., Hwang S.K., Jin H., Kim D.S., Minai-Tehrani A., Yoon H.J., Choi M., Yoon T.J., Han D.Y., Kang Y.W., Yoon B.I., Lee J.K., Cho M.H. Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J. Occup. Health 2008, 50:1-6.
273. Lasagna-Reeves C., Gonzalez-Romero D., Barria M.A., Olmedo I., Clos A., Sadagopa Ramanujam V.M., Urayama A., Vergara L., Kogan M.J., Soto C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem. Biophys. Res. Commun. 2010, 393:649-655.
274. Lockman P.R., Koziara J.M., Mumper R.J., Allen D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J. Drug Target. 2004, 12:635-641.
275. Long T.C., Saleh N., Tilton R.D., Lowry G.V., Veronesi B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ. Sci. Technol. 2006, 40:4346-4352.
276. 2 delivered to the abdominal cavity. Biomaterials 2010, 31:99-105.
277. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000, 283:1571-1577.
278. Nemmar A., Vanbilloen H., Hoylaerts M.F., Hoet P.H., Verbruggen A., Nemery B. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am. J. Respir. Crit. Care. Med. 2001, 164:1665-1668.
279. 60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect. 2004, 112:1058-1062.
280. Oberdorster G., Utell M.J. Ultrafine particles in the urban air: to the respiratory tract - and beyond?. Environ. Health Perspect. 2002, 110:A440-A441.
281. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Lunts A., Kreyling W., Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health A 2002, 65:1531-1543.
282. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 2004, 16:437-445.
283. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
284. Oddo S., Caccamo A., Kitazawa M., Tseng B.P., LaFerla F.M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiology of Aging. 2003, 24:1063-1070.
285. Oszlanczi G., Papp A., Szabo A., Nagymajtenyi L., Sapi A., Konya Z., Paulik E., Vezer T. Nervous system effects in rats on subacute exposure by lead-containing nanoparticles via the airways. Inhal. Toxicol. 2011, 23:173-181.
286. Porter D.W.H.A., Sriram K., Wu N., Wolfarth M., Hamilton R., Buford M. Engineered titanium dioxide nanowire toxicity in vitro and in vivo. The Toxicologist 2008, 102:306. (abstract) available at. http://www.toxicology.org/ms/AMpubs.asp.
287. Qian Z.M., Shen X. Brain iron transport and neurodegeneration. Trends Mol. Med. 2001, 7:103-108.
288. Rahman M.F., Wang J., Patterson T.A., Saini U.T., Robinson B.L., Newport G.D., Murdock R.C., Schlager J.J., Hussain S.M., Ali S.F. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett. 2009, 187:15-21.
289. Sharma H.S., Sharma A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog. Brain Res. 2007, 162:245-273.
290. Sharma H.S., Ali S.F., Hussain S.M., Schlager J.J., Sharma A. Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J. Nanosci. Nanotechnol. 2009, 9:5055-5072.
291. Sharma H.S., Hussain S., Schlager J., Ali S.F., Sharma A. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta. Neurochir. Suppl. 2010, 106:359-364.
292. Shimada A., Kawamura N., Okajima M., Kaewamatawong T., Inoue H., Morita T. Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse. Toxicol. Pathol. 2006, 34:949-957.
293. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 1996, 36:83-106.
294. Sonavane G., Tomoda K., Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B. Biointerfaces 2008, 66:274-280.
295. Sriram K., Porter D.W., Tsuruoka S., Endo M., Jefferson A.M., Wolfarth M.G., Rogers G.M., Castranova V., Luster M.I. Neuroinflammatory responses following exposure to engineered nanomaterials. Toxicologist 2007, 96:288. (abstract) available at. http://www.toxicology.org/ms/AMpubs.asp.
296. Sriram K., Porter D.W., Jefferson A.M., Lin G.X., Wolfarth M.G., Chen B.T., McKinney W., Frazer D.G., Castranova V. Neuroinflammation and blood-brain barrier changes following exposure to engineered nanomaterials. Toxicologist 2009, 108:458. (abstract) available at. http://www.toxicology.org/ms/AMpubs.asp.
297. Staubli U., Ivy G., Lynch G. Hippocampal denervation causes rapid forgetting of olfactory information in rats. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:5885-5887.
298. Tang J., Xiong L., Wang S., Wang J., Liu L., Li J., Yuan F., Xi T. Distribution, translocation and accumulation of silver nanoparticles in rats. J. Nanosci. Nanotechnol. 2009, 9:4924-4932.
299. Thompson K.J., Shoham S., Connor J.R. Iron and neurodegenerative disorders. Brain Res. Bull. 2001, 55:155-164.
300. Tin Tin Win S., Yamamoto S., Ahmed S., Kakeyama M., Kobayashi T., Fujimaki H. Brain cytokine and chemokine mRNA expression in mice induced by intranasal instillation with ultrafine carbon black. Toxicol. Lett. 2006, 163:153-160.
301. 2 nanoparticles in the anatase and rutile crystal phases. Toxicol. Lett. 2008, 183:72-80.
302. Wang J.X., Li Y.F., Zhou G.Q., Li B., Jiao F., Chen C.Y., Gao Y.X., Zhao Y.L., Chai Z.F. [Influence of intranasal instilled titanium dioxide nanoparticles on monoaminergic neurotransmitters of female mice at different exposure time]. Zhonghua yu fang yi xue za zhi [Chinese Journal of Preventive Medicine] 2007, 41:91-95.
303. Yamago S., Tokuyama H., Nakamura E., Kikuchi K., Kananishi S., Sueki K., Nakahara H., Enomoto S., Ambe F. In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem. Biol. 1995, 2:385-389.
304. Zhang L., Bai R., Liu Y., Meng L., Li B., Wang L., Xu L., Le Guyader L., Chen C. The dose-dependent toxicological effects and potential perturbation on the neurotransmitter secretion in brain following intranasal instillation of copper nanoparticles. Nanotoxicology 2011, 6:562-575.
305. Kan H., Wu Z., Young S.H., Chen T.H., Cumpston J.L., Chen F., Kashon M.L., Castranova V. Pulmonary exposure of rats to ultrafine titanium dioxide enhances cardiac protein phosphorylation and substance P synthesis in nodose ganglia. Nanotoxicology 2012, 6:736-745.
306. Knuckles T.L., Yi J., Frazer D.G., Leonard H.D., Chen B.T., Castranova V., Nurkiewicz T.R. Nanoparticle inhalation alters systemic arteriolar vasoreactivity through sympathetic and cyclooxygenase-mediated pathways. Nanotoxicology 2012, 6:724-735.
307. LeBlanc A.J., Cumpston J.L., Chen B.T., Frazer D., Castranova V., Nurkiewicz T.R. Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. J. Toxicol. Environ. Health A 2009, 72:1576-1584.
308. LeBlanc A.J., Moseley A.M., Chen B.T., Frazer D., Castranova V., Nurkiewicz T.R. Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism. Cardiovasc. Toxicol. 2010, 10:27-36.
309. Legramante J.M., Valentini F., Magrini A., Palleschi G., Sacco S., Iavicoli I., Pallante M., Moscone D., Galante A., Bergamaschi E., Bergamaschi A., Pietroiusti A. Cardiac autonomic regulation after lung exposure to carbon nanotubes. Hum. Exp. Toxicol. 2009, 28:369-375.
310. Li Z., Hulderman T., Salmen R., Chapman R., Leonard S.S., Young S.H., Shvedova A., Luster M.I., Simeonova P.P. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ. Health Perspect. 2007, 115:377-382.
311. Nurkiewicz T.R., Porter D.W., Barger M., Millecchia L., Rao K.M., Marvar P.J., Hubbs A.F., Castranova V., Boegehold M.A. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ. Health Perspect. 2006, 114:412-419.
312. Nurkiewicz T.R., Porter D.W., Hubbs A.F., Cumpston J.L., Chen B.T., Frazer D.G., Castranova V. Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part Fibre. Toxicol. 2008, 5:1.
313. Nurkiewicz T.R., Porter D.W., Hubbs A.F., Stone S., Chen B.T., Frazer D.G., Boegehold M.A., Castranova V. Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol. Sci. 2009, 110:191-203.
314. Stapleton P.A., Minarchick V., Cumpston A., McKinney W., Chen B.T., Frazer D., Castranova V., Nurkiewicz T.R. Time-course of improved coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation. Toxicol. Sci. (The Toxicologist) 2011, 120(S2):A194. (abstract) available at.
315. Aiso S., Kubota H., Umeda Y., Kasai T., Takaya M., Yamazaki K., Nagano K., Sakai T., Koda S., Fukushima S. Translocation of intratracheally instilled multiwall carbon nanotubes to lung-associated lymph nodes in rats. Ind. Health 2011, 49:215-220.
316. Baluk P., McDonald D.M. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann. NY. Acad. Sci. 2008, 1131:1-12.
317. Choi H.S., Ashitate Y., Lee J.H., Kim S.H., Matsui A., Insin N., Bawendi M.G., Semmler-Behnke M., Frangioni J.V., Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 2010, 28:1300-1303.
318. El-Chemaly S., Levine S.J., Moss J. Lymphatics in lung disease. Ann. NY. Acad. Sci. 2008, 1131:195-202.
319. El-Chemaly S., Malide D., Zudaire E., Ikeda Y., Weinberg B.A., Pacheco-Rodriguez G., Rosas I.O., Aparicio M., Ren P., MacDonald S.D., Wu H.P., Nathan S.D., Cuttitta F., McCoy J.P., Gochuico B.R., Moss J. Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3958-3963.
320. Elias A., Tsourkas A. Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program 2009, 720-726.
321. Harmsen A.G., Muggenburg B.A., Snipes M.B., Bice D.E. The role of macrophages in particle translocation from lungs to lymph nodes. Science 1985, 230:1277-1280.
322. Harmsen A.G., Mason M.J., Muggenburg B.A., Gillett N.A., Jarpe M.A., Bice D.E. Migration of neutrophils from lung to tracheobronchial lymph node. J. Leukoc. Biol. 1987, 41:95-103.
323. Johnson L.A., Jackson D.G. Cell traffic and the lymphatic endothelium. Ann. NY. Acad. Sci. 2008, 1131:119-133.
324. Johnson L.A., Clasper S., Holt A.P., Lalor P.F., Baban D., Jackson D.G. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 2006, 203:2763-2777.
325. Johnson L.A., Prevo R., Clasper S., Jackson D.G. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J. Biol. Chem. 2007, 282:33671-33680.
326. Kobayashi H., Kawamoto S., Star R.A., Waldmann T.A., Tagaya Y., Brechbiel M.W. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res. 2003, 63:271-276.
327. Kobayashi H., Kawamoto S., Sakai Y., Choyke P.L., Star R.A., Brechbiel M.W., Sato N., Tagaya Y., Morris J.C., Waldmann T.A. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J. Natl. Cancer Inst. 2004, 96:703-708.
328. Kreyling W.G., Semmler-Behnke M., Seitz J., Scymczak W., Wenk A., Mayer P., Takenaka S., Oberdorster G. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal. Toxicol. 2009, 21(Suppl. 1):55-60.
329. Lauweryns J.M., Baert J.H. The role of the pulmonary lymphatics in the defenses of the distal lung: morphological and experimental studies of the transport mechanisms of intratracheally instillated particles. Ann. NY. Acad. Sci. 1974, 221:244-275.
330. Leak L.V. Lymphatic removal of fluids and particles in the mammalian lung. Environ Health Perspect 1980, 35:55-75.
331. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 2008, 38:1404-1413.
332. Mayerson H.S. On Lymph and Lymphatics. Circulation 1963, 28:839-842.
333. Morrow P.E. Lymphatic drainage of the lung in dust clearance. Ann. NY. Acad. Sci. 1972, 200:46-65.
334. Ohtani O., Ohtani Y. Structure and function of rat lymph nodes. Arch. Histol. Cytol. 2008, 71:69-76.
335. Pepper M.S., Skobe M. Lymphatic endothelium: morphological, molecular and functional properties. J. Cell Biol. 2003, 163:209-213.
336. Ravizzini G., Turkbey B., Barrett T., Kobayashi H., Choyke P.L. Nanoparticles in sentinel lymph node mapping. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1:610-623.
337. Riviere J.E. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1:26-34.
338. Yang D., Yang F., Hu J., Long J., Wang C., Fu D., Ni Q. Hydrophilic multi-walled carbon nanotubes decorated with magnetite nanoparticles as lymphatic targeted drug delivery vehicles. Chem. Commun. (Camb) 2009, 4447-4449.
339. Yang F., Jin C., Yang D., Jiang Y., Li J., Di Y., Hu J., Wang C., Ni Q., Fu D. Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment. Eur. J. Cancer 2011, 47:1873-1882.
340. Hubbs A., Greskevitch M., Kuempel E., Suarez F., Toraason M. Abrasive blasting agents: designing studies to evaluate relative risk. J. Toxicol. Environ. Health A. 2005, 68:999-1016.
341. Hubbs A.F., Mercer R.R., Benkovic S.A., Harkema J., Sriram K., Schwegler-Berry D., Goravanahally M.P., Nurkiewicz T.R., Castranova V., Sargent L.M. Nanotoxicology - a pathologist's perspective. Toxicol. Pathol. 2011, 39:301-324.
342. Kuempel E.D., O'Flaherty E.J., Stayner L.T., Smith R.J., Green F.H., Vallyathan V. A biomathematical model of particle clearance and retention in the lungs of coal miners. Regul. Toxicol. Pharmacol. 2001, 34:69-87.
343. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Schwegler-Berry D., Castranova V., Porter D.W. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre. Toxicol. 2010, 7:28.
344. Chen X., Shank S., Davis P.B., Ziady A.G. Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid. Mol. Ther. 2011, 19:93-102.
345. Cheng T.H., Ko F.C., Chang J.L., Wu K.A. Bronchiolitis obliterans organizing pneumonia due to titanium nanoparticles in paint. Ann. Thorac. Surg. 2012, 93:666-669.
346. Choi H.S., Ashitate Y., Lee J.H., Kim S.H., Matsui A., Insin N., Bawendi M.G., Semmler-Behnke M., Frangioni J.V., Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 2010, 28:1300-1303.
347. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2003, 422:37-44.
348. Dombu C.Y., Kroubi M., Zibouche R., Matran R., Betbeder D. Characterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cells. Nanotechnology 2010, 21:355102.
349. Ferin J., Oberdorster G., Penney D.P. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 1992, 6:535-542.
350. Howes M.T., Kirkham M., Riches J., Cortese K., Walser P.J., Simpson F., Hill M.M., Jones A., Lundmark R., Lindsay M.R., Hernandez-Deviez D.J., Hadzic G., McCluskey A., Bashir R., Liu L., Pilch P., McMahon H., Robinson P.J., Hancock J.F., Mayor S., Parton R.G. Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J. Cell Biol. 2010, 190:675-691.
351. International Life Sciences Institute The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. ILSI Risk Science Institute Workshop Participants. Inhal. Toxicol. 2000, 12:1-17.
352. Kuempel E.D., O'Flaherty E.J., Stayner L.T., Smith R.J., Green F.H., Vallyathan V. A biomathematical model of particle clearance and retention in the lungs of coal miners. Regul. Toxicol. Pharmacol. 2001, 34:69-87.
353. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L., Battelli L.A., Friend S., Castranova V., Porter D.W. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre. Toxicol. 2011, 8:21.
354. Nikula K.J., Vallyathan V., Green F.H., Hahn F.F. Influence of exposure concentration or dose on the distribution of particulate material in rat and human lungs. Environ. Health Perspect. 2001, 109:311-318.
355. Oberdorster G. Lung particle overload: implications for occupational exposures to particles. Regul. Toxicol. Pharmacol. 1995, 21:123-135.
356. Oberdorster G. Toxicology of ultrafine particles: in vivo studies. Philosophical Transactions of the Royal Society of London Series A - Mathematical Physical and Engineering Sciences 2000, 358:2719-2739.
357. Oberdorster G., Utell M.J. Ultrafine particles in the urban air: to the respiratory tract - and beyond?. Environ. Health Perspect. 2002, 110:A440-A441.
358. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Lunts A., Kreyling W., Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health A. 2002, 65:1531-1543.
359. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 2004, 16:437-445.
360. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre. Toxicol. 2005, 2:8.
361. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
362. Oberdorster G., Stone V., Donaldson K. Toxicology of nanoparticles: A historical perspective. Nanotoxicology 2007, 1:2-25.
363. Phillips J.I., Green F.Y., Davies J.C., Murray J. Pulmonary and systemic toxicity following exposure to nickel nanoparticles. Am. J. Ind. Med. 2010, 53:763-767.
364. Song Y., Li X., Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur. Respir. J. 2009, 34:559-567.
365. Han J.H., Lee E.J., Lee J.H., So K.P., Lee Y.H., Bae G.N., Lee S.B., Ji J.H., Cho M.H., Yu I.J. Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal. Toxicol. 2008, 20:741-749.
366. Methner M.M., Birch M.E., Evans D.E., Ku B.K., Crouch K., Hoover M.D. Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations. J. Occup. Environ. Hyg. 2007, 4:D125-D130.
367. Rengasamy S., King W.P., Eimer B.C., Shaffer R.E. Filtration performance of NIOSH-approved N95 and P100 filtering facepiece respirators against 4 to 30 nanometer-size nanoparticles. J. Occup. Environ. Hyg. 2008, 5:556-564.